Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content Volume 12 Issue 1 - October 2019

 

A study to identify and assess the sonological features in patients with clinical features of polycystic ovarian syndrome

Rajashekhar Muchchandi1*, Nandini Takalaki2

 

{1Associate Professor, Department of Radiology} {2Assistant Professor, Department of Biochemistry} Al-Ameen Medical College, Vijayapura, Karnataka, INDIA.

Email: radioraj@gmail.com

 

Abstract               Background and Objectives: Polycystic ovarian syndrome is a heterogeneous endocrine disorder affecting women of reproductive age group characterized by a combination of polycystic ovarian morphology, clinical features and biochemical indices. The objective of this study was to identify the sonological features of ovaries and endometrium. Methodology: Pelvic ultrasonography was performed in the patients clinically suspected of having polycystic ovarian syndrome. Previously established cases of polycystic ovarian syndrome and patients with any other known health problems were excluded. Statistical analysis included only those patients having complete data. Results: The age range of 60 patients with clinically suspected polycystic ovary syndrome was 15 to 35 years. The mean age distribution was 26 years. Majority (66.67%) of the patients were below 25 years. Majority (70%) of the patients were unmarried. Most(70%) of the patients showed more than 12 follicles per ovary and peripheral arrangement of the follicles was the most common finding in these patients and it was observed in all. Maximum number (83.33%) of the patients showed 2-9mm follicles.≥ 10cc volume was observed in 62% of the patients. Volume range was 7cc to 24cc. 37 % had stromal thickness more than 10mm. Stromal thickness range was 7mm to 14mm. In 98.33 % of the ovaries stroma appeared echogenic. Conclusion: The sonological ovarian features in patients with clinical suspicion of polycystic ovarian syndrome correlated well with clinical features

Key Words: Polycystic ovarian syndrome, pelvic sonography, sonological ovarian features

 

 

INTRODUCTION

Polycystic ovarian syndrome (PCOS) is a common endocrinopathy in women of reproductive age group and an incompletely understood enigmatic disorder of heterogenous nature. It starts appearing at 15 to 25 years of age and it may take years for its clinical presentation to appear. The incidence of polycystic ovarian syndrome is 4% to 22% of women overall and 50% of women seen at infertility clinics1, 2. Polycystic ovarian syndrome was first described by Irving Stein and Michael Leventhal in 1935 in a group of patients presenting with amenorrhea, bilateral polycystic ovaries, and masculinising changes which might, according to them be due to the result of some hormonal stimulation very likely related to the anterior lobe of pituitary. Even after seventy years, the underlying cause for its heterogeneity and the development of signs and symptoms is not identified, the diagnostic criteria have yet to be universally agreed upon and the pathophysiology remains a point of intense research and debate.3 PCOS is characterized by low follicle stimulating hormone levels resulting in anovulation, elevated luteinizing hormone levels, resulting in hyperandrogenism, and insulin-resistance symptoms which may range from simple cystic acne, cephalic hair loss, or mild facial hirsutism to instances of oligomenorrhoea or amenorrhoea, sterility and severe generalized hirsutism. Classical Stein Leventhal syndrome which manifests as amenorrhoea, hirsutism,sterility and obesity is one extreme form in the broad spectrum of clinical manifestations of PCOS. Chronic anovulation results in endometrial hyperplasia and heterogenous cystic endometrium due to unopposed estrogens1. In clinical practice women with polycystic ovarian syndrome are seen for three major reasons. Infertility (mean incidence 74%), menstrual irregularities (mean incidence of dysfunctional uterine bleeding 29%, and amenorrhoea 51%) and androgen excess (mean incidence of hirsutism 69%, virilisation 21%).4 The diagnosis of PCOS depends on confirming the hyperandrogenism and excluding other causes of hyperandogenic anovulation. Originally, according to Stein and Leventhal (1935) the diagnosis required pathognomonic ovarian findings and the clinical triad of hirsutism, amenorrhea, and obesity. The next diagnostic milestone occurred 30 years later, when researchers in the late 1960s and early 1970s noted derangements in the hypothalamo-pituitary axis. Following this the endocrine criteria were added to the diagnosis such as elevated levels of serum testosterone, and an elevated LH: FSH ratio.4 Pelvic ultrasonography in the 1970s further added diagnostic specificity to the recognition of PCOS. Ultrasound features of polycystic ovaries were included as a diagnostic criterion following the Rotterdam Consensus meeting for PCOS diagnosis in 2003. The three criteria included in the definition were: i) oligo and/or anovulation; ii) hyperandrogenism and iii) polycystic ovaries with the exclusion of other etiologies. This definition required at least the presence of two from the above three criteria.5 Thus PCOS has evolved through many steps from the clinical, biochemical and imaging perspectives. Further, advances in imaging technology, particularly transvaginal sonography, have qualitatively enhanced the information on the internal structure of ovary and endometrial morphology.With this background, the present study was undertaken to identify and assess the sonological features in patients with clinical features of polycystic ovarian syndrome.

 

METHODOLOGY

Study setting: - Department of radiology, Sri Siddhartha medical college, Tumkur, Karnataka department of radiology

Study design: - Prospective cross sectional study.

Source of data:- 60 female patients in age group of 15-35 years referred from the Obstetrics and Gynaecology department of Sri Siddhartha medical college, Tumkur for pelvic ultrasonography were included in this study.

METHOD OF COLLECTION OF DATA

A prospective study of 60 female patients in reproductive age group.

Evaluation of ovarian morphology and endometrium by pelvic ultrasonography by transvaginal and transabdominal (in those patients where transvaginal was contraindicated).

INCLUSION CRITERIA:

Patients referred from Obstetric and Gynecology department with clinical suspicion of features of polycystic ovarian syndrome for pelvic sonography. The specific inclusion criteria included were the following:

             Female patients in reproductive age group (15 – 35 years)

             Irregular or no Menstrual periods

             Hirsuitism / Acne (Androgen excess)

             Infertility

             Obesity

EXCLUSION CRITERIA:

             Known cases of Polycystic ovarian syndrome on treatment and follow up

             Less than 15 years or greater than 35 years age group

             Patients with other known or incidentally detected health problems.

             Patients without hormonal investigations

             Patients lost for follow up

 

EQUIPMENT AND PROTOCOL:

Transabdominal Ultrasonography:-

The study was performed using GE- VOLUSON 730 PRO, GE LOGIQ 500 PRO ultrasound scanners using convex probes of frequency ranging from 3 to 5 MHZ.

Transvaginal or Endovaginal Ultrasonography:-

The study was performed using GE- VOLUSON 730 PRO, GE LOGIQ 500 PRO ultrasound scanner using curved probes of frequency ranging from 7 to 10 MHZ.

Statistical analysis:

Data was entered into Microsoft excel data sheet and was analyzed using SPSS 22 version software. Categorical data was represented in the form of Frequencies and proportions. Chi-square test or Fischer’s exact test (for 2x2 tables only) was used as test of significance for qualitative data.

Correlations were performed with Pearson Correlation coefficient

P value (Probability that the result is true) of <0.05 was considered as statistically significant after assuming all the rules of statistical tests.


 

 

RESULTS

The age range of 60 patients with clinically suspected polycystic ovary syndrome was 15 to 35 years. The mean age distribution was 26 years. Majority (66.67%) of the patients were below 25 years. Majority (70%) of the patients were unmarried.

Table 1: Distribution of patients according to Chief complaints

Chief complaints

Number of patients

%

Oligomenorrhea

48

80

Obesity

21

35

Hirsutism

30

50

Infertility

16

26.67

 

Table 2: Distribution of patients according Type of sonological procedure done

 

Number of patients

%

TAB only

56

93.33

TVS + TAB

4

6.67

Total

89

100

Trans abdominal USG examination was performed in all patients and TVS was also performed in 4 patients.

 

Table 3: Arrangement, number and size of the follicles per ovary

Follicle distribution

Number of patients

%

Peripheral

60

100.0

Irregular

-

-

Total

60

100.0

Number of follicles

Number of patients

%

<12

18

30

≥12

42

70

Total

60

100.0

Follicle size (in mm)

Number of patients

%

<2.0

1

1.67

2.0-9.0

50

83.33

>9.0

9

15

Total

60

100.0

Most(70%) of the patients showed more than 12 follicles per ovary and peripheral arrangement of the follicles was the most common finding in these patients and it was observed in all. Maximum number (83.33%) of the patients showed 2-9mm follicles. ≥ 10cc volume was observed in 62% of the patients. . Volume range was 7cc to 24cc. 37 % had stromal thickness more than 10mm. Stromal thickness range was 7mm to 14mm. In 98.33 % of the ovaries stroma appeared echogenic.

Table 4: Correlation between duration of irregular menstruation, hirsutism with ovary and endometrium

 

 

Sonological features

Endometrial thickness

Follicle e no

follicle e size

Stromal thickness

s

Volume of ovary

Duration of Irregular menstruation

r value

0.203

0.219

0.012

0.239

0.318

p

value

0.284

0.030

0.250

0.714

0.070

 

Hirsutism

r value

0.021

0.008

0.034

0.131

0.213

p

value

0.384

0.312

0.250

0.124

0.030

Duration of the irregular menstruation has positive correlation with endometrial thickness and stromal thickness. But this is not statistically significant. Whereas duration of the irregular menstruation shown statistically significant positive correlation with follicle number and volume of the ovary. Hirsutism has positively significant correlation with volume of the ovary, whereas statistically insignificant positive association with stromal thickness.

DISCUSSION

The present study which included 60 patients who were clinically suspected of having polycystic ovarian syndrome was conducted. In our study The age range of 60 patients with clinically suspected polycystic ovary syndrome was 15 to 35 years. The mean age distribution was 26 years. Majority (66.67%) of the patients were below 25 years.Similar results were observed in the following studies. According to study conducted by Luciano G.Nardo and William M.Buckett, the mean age was 31 ±3.1years with age range of 26 to 37 years.In study by S.Jonard, Y.Robert the age range was 21 to 34 years with a median age of 27 years. It is a prospective study of 214 patients of polycystic ovarian syndrome.Range of age was 14 to 37 years with a mean age of 24 years in a study of 104 patients diagnosed as having polycystic ovarian syndrome by Hsu-Chong Yeh and Walter Futterweit. In our study Majority (70%) of the patients were unmarried.This observation was different from the results of the study conducted by Gayatri .M in 2001, out of 120 patients with polycystic ovarian syndrome most of the patients were married and 24% were unmarried. This study was mainly focussed for infertility management and this might be the reason for the difference. In the present study all of the patients (80%) had irregular periods particularly oligomenorrhea. The other main complaints of the patients were obesity which constituted about 35% of the patients followed by 50% of hirsutism and infertility 26.67%.These observations were similar to the study by Adams et al and Luciano G. Nardo et al. In this study along with oligomenorrhea (100%), infertility (85%) and hirsutism (65%) were the main complaints of the patients with polycystic ovarian syndrome.Study by Nagamani Peri et al in 245 patients with polycystic ovarian syndrome, 146 showed menstrual irregularities, 38 had hirsutism, 15 had infertility. The range of follicle number observed in the present study was between 10 and 20, with a mean of 12 ± 2. Maximum numbers of patients (70%) were in the group of ≥12follicles, 30% showed < 12 follicles. This cut off point was taken as per the Rotterdam consensus definition of polycystic ovarian syndrome.If the cut off point was ≥ 10 follicles following the criteria of Adams et al, 100% of the patients in the present included in this group. Present study showed peripheral distribution of follicles in 100% of the patients. This observation was seen in many other studies by Adams J, 60% in peripheral distribution and 40 % in irregular distribution, Ardaens Y. 55% in irregular and scattered, 45 % in peripheral distribution, Hann LE 73% in peripheral distribution. The range of follicle size in this study was between 2 to 10mm. Mean size observed was 4mm. Most common size range observed in this study was 2-9mm which was seen in 83.33% of the patients. >9mm follicles were seen in 15% of the patients and <2 mm in 1.67%. This observation was supported by other studies by Adams et al, Polson et al, Conway et al whose studies observed 2-9mm was the most common (> 60%) follicular size in patients with polycystic ovarian syndrome. Hann et al found that mean follicular size was 5mm±1, with range 2 to 12mm, and most common follicular size observed was 2-9mm (80%).Adams et al described < 8mm was the most common size of the follicle. The subjective evaluation of the stroma in this present study showed echogenic and thickened in 98% of the patients and non echogenic and thin in 2% of the patients. This observation was supported by Hughesdon et al, and Ardaens et al. The quantitative measurement of the stromal thickness in this present study ranged between 2 mm to 14mm. In this present study <10 mm stromal thickness was seen in majority (65.2%) of the patients, whereas ≥10 mm was seen in 34.8% of the patients. Study by Hughesdon et al described the echogenicity of the stroma in their study and showed significant histopathological correlation. Ardaens et al subjectively assessed the echogenicity and confirmed with transvaginal scan.In the study by Pache et al increase in stromal echogenicity was found in 55%, with ≥10 mm as the cut off point. The volume range observed in the present study was between 7 to 14 mm. When ≥ 10cc was taken as the criteria for polycystic ovarian syndrome according to Rotterdam consensus meeting, this study was observed ≥ 10cc volume in most (63%) of the patients and in 37.1% the volume was less than 10cc.This observation was supported by Adams et al, most 70% of the PCOS patients showed ≥ 10cc.Hann et.al., study showed ≥ 10cc in 71% and normal ovarian volume in about 29%. The present study observed significant rise in the number of follicles and volume of the ovary with increase in the duration of the irregular menstruation. There is significant rise in the volume of the ovary with increase in the severity of the Hirsutism. And also endometrial thickness and stromal thickness are more with increase in duration of irregular menstruation. But this was not statistically significant. The intra-ovarian hyperandrogenism promotes excessive early follicular growth up to the 2-5mm stage independently from LH and inhibits apoptosis. This physiological process was exaggerated in polycystic ovarian syndrome The other reason for this follicular number and size of the follicles could be the further growth of the follicle to the dominant follicle cannot be proceed because of the follicular arrest by this hyperandrogenism and lower FSH levels in polycystic ovarian syndrome patients. This increase in follicle number and increase in stroma because of hyperandrogenism (raised testosterone levels) adds to the bulk of the ovary. The reason for the increase in endometrial thickness could be prolonged exposure to excessive estrogen levels and also irregular periods i.e. increase in the length of the cycle. These results of the study were supported by study by Wickenheisser et al.

 

CONCLUSION

The sonological ovarian features in patients with clinical suspicion of polycystic ovarian syndrome correlated well with clinical features. It was observed that endometrial thickness and stromal thickness are more with increase in duration of irregular menstruation. Ovarian volume, number of follicles show positive correlation with duration of the irregular menstruation and hirsutism.

 

ACKNOWLEDGEMENTS

Authors would like to acknowledge all the subjects participated in the study. Everyone who contributed in the completion of the study including the technical staff

 

REFERENCES

  1. Nagamani Peri, Deborah Levine. Sonographic evaluation of the endometrium in patients with a history or an appearance of polycystic ovarian syndrome. J Ultrasound Med 2007; 26: 55-58.
  2. Belinda MS, Richard PD. Polycystic ovarian syndrome and the metabolic syndrome.Am J Med Sci 2005;330(6):336-342.
  3. Abdel Gadir A, Khatim MS, Mowafi RS, Alnaaser HM, Muharib NS, Shaw RW. Implications of ultrasonically diagnosed polycystic ovaries. Its correlations with basal hormonal profiles. Human reproduction 1992;7(4): 453-7.
  4. Takahashi K, Eda Y, Abu Musa A, Okada S, Yoshino K, Kitao M. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome. Human Reproduction 1994; 9:1231-1236.
  5. Adam HB, Joop SE, Seang-Lin Tan, Didier Dewailly. Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update 2003; 9:505-514.
  6. Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic syndrome: the ovarian stroma / total area ratio. Fertil Steril 2001;76:326-331.
  7. Carranza-Lira S, Magana-Padilla NR. Ultrasonographic and lipid changes in polycystic ovary syndrome according to type of treatment. Gynecol Obstet Mex 2002; 70: 285-8.
  8. Cesare Battaglia, Nicola Persico, Pierandrea de laco, Fulvia Mancini, Paolo Busacchi, Domenico de Aloysio. The ultrasound review of Obstetrics and gynecology 2005; 5:316-324.
  9. Swanson M, Sauerbrei EE, Cooperberg PL. Medical implications of ultrasonically detected polycystic ovaries. Journal of Clinical Ultrasound 1981; 9:219-222.
  10. Sahana SN. Human anatomy-descriptive and applied. 3rd ed.Howrah:K.K.Publishers;1989.P.380-396.(vol.2)
  11. Tasoula Tsilchorozidou, Caroline Overton, Gerard Conway S. The pathophysiology of polycystic ovary syndrome. Clinical Endocrinolology 2004;60:1-17.
  12. Amma A, Kyei-Mensah, Seang Lin Tan, Jamal Zaidi, Howard Jacob.S. Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Human reproduction 1998; 13: 1437-1441.
  13. Fulghesu AM, Angioni s, Frau C, Belosi, Apa, Mioni R, et al. Ultrasound in polycystic ovary syndrome-the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Human reproduction 2007;22: 2501-2508.
  14. Douglas L, Tara L, Henrichsen, Amy c, Susan, Hudson, Charles C, Adrian Vella. Ovarian stromal Hyperthecosis: Sonographic features and histologic associations. Jultrasound Med 2009; 28:587-593.
  15. Luciano GN, William Buckest M, Daviana White, Alessandro Digesu G, Stephen Franks, Vik Khullar. Three dimensional assessment of ultrasound features in women with Clomiphene citrate-resistant polycystic ovarian syndrome (PCOS): ovarian stromal volume does not correlate with biochemical indices. Human reproduction 2002; 17:1052-1055.
  16. David S, Guzick. Polycystic ovary syndrome. Am J Obstet Gynecol 2000; 103:181-193.
  17. Roger Hart. Polycystic ovarian syndrome-prognosis and treatment outcomes. Current opinion in obstetrics and gynaecology 2007;19:529-535.
  18. Rogerio A, Lobo, Enrico Carmina. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 2000; 132:989-993.
  19. Tack D, De Maertelaer, Petit, Scilla P, Muller p, Hann LE, Hall DA et al. Polycystic ovarian disease: sonographic spectrum. Radiology 1984;150(2):531-4.
  20. Joseph Itskovitz, Rafael Bolddes, Jacob Levron, Israel Thaler. Transvaginal ultrasonography in the diagnosis and treatment of infertility. Journal of clinical ultrasound 2005;18 :248-256.
  21. Hsu-Chong Yeh, Walter Futterweit, John Thornton C. Polycystic ovarian disease: US features in 104 patients. Radiology 1987;163:111-116.
  22. Munn CS, Kaiser LC, Wetzner SM, Baer JE. Ovary volume in young and premenopausal adult: Ultrasound determination. Radiology 1986; 159:731- 732.
  23. Hann LE, Hall DA, Mc Ardle CR, Seibel M. Polycystic ovarian disease: sonographic spectrum. Radiology 1984; 150(2): 531-534.
  24. Mausumi Sadhukhan, William U, Atiomo, Paul Dubbins. Polycystic ovary syndrome: Where are we now? Journal of women’s imaging 2002; 4:21-30.
  25. Insler V, Shoham Z, Baraash A, Koistinen R, Seppala M, Hen M, Lunenfeld B, Zadik Z. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Human Reproduction 1993; 8(3):379-84.
  26. Wu MH, Tang HH, Hsu CC, Wang ST, Huang KE. The role of three- dimensional ultrasonographic images in ovary measurement. Fertil Steril 1998; 69: 1152-5.
  27. Miguel Dolz, Newton G, Osborne, Javier Blanes, Francisco Raga, Lorenzo Abad-Velasco et al. Polycystic ovarian syndrome: Assessment with color Doppler angiography and three dimensional ultrasonography. J Ultrasound Med 1999; 18:303-313.
  28. Donald GM, Warren BG, Charles ES, Luis Blasco, JohnNulson, Virginia Livolsi et al. Polycystic ovaries:MR Imaging.Radiology 1986;160:425-429.
  29. Venturoli S, Porcu E, Fabbri R. Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycle of adolescents. Pediatric Research1995;38:974-980.
  30. Orsini LF, Venturoli S, Lorusso r, Paradidi R, Bovicelli L. Ultrasonographic findings in polycystic ovarian disease. Fertil Steril 1985;43(5):709-14.
  31. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Blackwell Scientific 1992; 159:377-384.
  32. Ardaens Y, Robert Y, Lemaitre L, Fossati P, Dewailly D. Polycystic ovarian disease-contribution of vaginal endosonography and reassessment of ultrasonic diagnosis, Fertil Steril 1991;55:1062-1068.
  33. Ballen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reproduction Update 2003; 9:505-514.
  34. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. American Journal.of Obestetrics and Gynecology 2001; 29:181-191
  35. Zweig MH, Campbell G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry 1993; 39: 561-577.
  36. Nicolini U, Ferrazzi E, Bellotti M, Travaglini P, Elli R, Scaperrotta RC. The contribution of sonographic evaluation of ovarian size in patients with polycystic ovarian disease, Journal of Ultrasound Medicine 1985; 4:341- 351.
  37. Pache TD, Wladimiroff JW, Hop WC, Fauser BC, How to discriminate between normal and polycystic ovaries: trans-vaginal ultrasound study, Radiology 1992, 183 (2):421-423
  38. Adams J, Polson DW, Abdul wahid N, Morris DV, Franks S, Mason HD, et.al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing harmone. Lancet 1985; 2: 1375-1379.
  39. Fox R, Corrigan E, Thomas PA, Hull MG. The diagnosis of polycystic ovaries in women with oligo-amenorrhea: predictive power of endocrine tests. Clinical endocrinology 1991; 34:127-131.
  40. Nardo LG, Buckett WM, Khullar V. Determination of the best fitting ultrasound formulaic method for ovarian volume measurement in women with polycystic ovary syndrome. Fertil Steril 2003; 79:632- 633.
  41. Orsini LF, Rizzo N, Calderoni P, Pilu G, Bovicelli L. Ultrasound monitoring of ovarian follicular development: a comparison of real-time and scanning techniques. Journal Clinical Ultrasound 1983; 11: 207-211.
  42. Sample WF, Lippe BM, and Gyepes MT. Grey-scale ultrasonography of the normal pelvis. Radiology 1997; 125: 477-483.
  43. Saxton DW, Farquhar CM, Rae T, Beard RW, Anderson MC, Wadsworth J. Accuracy of ultrasound measurements of female pelvic organs. British. Journal of Obstetrics and Gynecology 1990;97:695-699.
  44. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Human reproduction 2003; 18:598-603